AI assistant
Anterix Inc. — Director's Dealing 2020
Aug 20, 2020
33018_dirs_2020-08-19_4262df9f-b728-490e-8a71-f2c9472cb5d7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2020-08-18
Reporting Person: OBRIEN MORGAN E (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-18 | Common Stock | M | 3030 | $20.00 | Acquired | 85621 | Direct |
| 2020-08-18 | Common Stock | S | 3030 | $44.761 | Disposed | 82591 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-08-18 | Stock Option (Right to Buy) | $20.00 | M | 3030 | Disposed | 2024-05-14 | Common Stock (3030) | Direct |
Footnotes
F1: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the exercise of stock options.
F2: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.52 to $45.11. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3: The option shares are fully vested.